Regional Haematology Program: Clinical Trials
In this comprehensive overview, Kate Khamly, Program Manager from the Victorian Comprehensive Cancer Centre , delivers an extensive overview of hematology clinical trials, explaining their key components and touching on the drug discovery process.
This resource is part of a suite of four videos created to support health professionals involved in the care of haematology patients. The four topics include hematological diseases: Lymphoma, Myeloma and Haematology Clinical Trials.
Aim: This resource aims to provide an introductory overview of Haematology clinical trials
The topics covered in this video include:
-
What is a clinical trial?
-
Drug Discovery Process
-
Who is involved in clinical trials?
-
Key components
-
The critical role of site staff
-
Informed Consent
-
Data Management
Hematological Diseases: Clinical Trials
Select play to watch the video
Copyright notice: All content is general in nature and reflects the presenter’s experiences and expertise, and may not reflect VCCC Alliance’s views. All content is owned by the VCCC Alliance. It is shared with you for your personal purposes, and is not to be otherwise shared, adapted or copied in any way. VCCC Alliance does not warrant that the content will satisfy required continuing professional development units, unless otherwise stated.
Kate Khamly
Kate Khamly is the Manager of Clinical Research, Cancer Research Division at Peter MacCallum Cancer Centre.
Find Out More
Haematology Online Learning Modules
Elevate Your Haematology Training with the VCCC Alliance
Experience the future of haematology training with our cutting-edge suite of five online resources.
Developed by the VCCC Alliance, this suite of five online dynamic modules is designed to empower you both now and in the future in the haematology training program. Immerse yourself in real-life case studies, featuring expert presenters and engaged registrars, as they dissect and discuss captivating scenarios.